hdmASIT+TM peptides

hdmASIT+TM peptides · ASIT Biotech S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hdmASIT+TM peptides, covering 2017-03-29 to 2017-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients [Phase 2]